Abstract Purpose: To evaluate antibacterial activity of a series of molecules bearing 1,3,4-oxadiazole and azomethine moieties.
INTRODUCTION
Bacteria have developed resistance to several antibiotics over time. Scientists have continued for several years to discover new potent molecules with remarkable activities [1] . Heterocyclic compounds have often been synthesized because of their broad spectrum of biological activities [2] . The 2,5-substituted-1,3,4-oxadiazole derivatives, which have often been synthesized in the last decade, exhibit a number of biological activities [3] [4] [5] [6] [7] . In continuation of a previous synthetic work using 1,3,4-oxadiazole derivatives [8, 9] , N-substituted derivatives of 2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazide have been synthesized in this study to determine their antibacterial potential.
EXPERIMENTAL General
Melting points of the synthesized compounds were carried out in a Griffin-George apparatus with open capillary tube and were uncorrected; I.R. spectral data by KBr pellet on a Jasco-320-A spectrophotometer; 1 H-NMR spectral data by Bruker spectrometer in dimethylsulfoxide (DMSO) at 600 MHz; and EIMS spectral data by JMS-HX-110 spectrometer. Purity was verified via thin layer chromatography (TLC) on precoated silica gel G-25-UV254 plates with ethyl acetateand n-hexane solvent systems.
Synthesis of ethyl 4-chlorobenzoate (2)
4-Chlorobenzoic acid (1; 5.0 g) was refluxed in 20.0 mL absolute ethanol and 2.0 mL concentrated H 2 SO 4 in a 250 mL round bottom (RB) flask for 3 h. After completion of the reaction which was verified by TLC, reaction mixture was taken up in a separating funnel followed by the addition of 200 mL distilled water and concentrated aqueous Na 2 CO 3 solution (pH = 8-10). 50 mL diethylether was employed to extract the ester from the aqueous layer which was obtained on evaporation.
Synthesis of 4-chlorobenzohydrazide (3)
Ethyl 4-chlorobenzoate (2; 0.03 mol) was stirred with 2.0 mL 80 % hydrazine hydrate in 15.0 mL methanol in a 100 mL RB flask for 2 h. After final TLC, the product was precipitated out by the addition of excess cold distilled water, separated by filtration and washed with n-hexane.
Synthesis of 5-(4-chlorophenyl)-1,3,4-oxadiazol-2-thiol (4)
The mixture of 4-chlorobenzohydrazide (3; 0.03 mol) and 50.0 mL absolute ethanol in a 250 mL RB flask was basified by KOH (0.03 mol) on reflux. Carbon disulfide (0.06 mol) was added at room temperature. The mixture was refluxed for 5 h till single spot on TLC. Excess cold distilled water was poured into the reaction flask and acidified by dilute HCl (pH of 2-3). The precipitates were filtered and washed with distilled water.
Synthesis of ethyl 2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetate (5)
The compound 4 (0.03 mol) was dissolved in 13 mL DMF in a 50 mL RB flask. NaH (0.12 g) was added and stirred for 30 min. Ethyl 2-bromoacetate (3.3 mL) was added and further stirred for 3.5 h. On single spot through TLC, excess ice cold distilled water was poured to flask for precipitation. The precipitates were isolated through filtration, washed and dried.
Synthesis of 2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazide (6)
The ester 5 (0.03 mol) in 20.0 mL methanol was stirred with 2.0 mL 80 % hydrazine hydrate strictly at room temperature in a 100 mL RB flask for 2.5 h. After complete reaction, the addition of excess cold distilled water resulted in precipitation. The product was separated by filtration and washed off by n-hexane.
Synthesis
of N'-substituted-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazide (8a-p)
The compound 6 (0.001 mol) was taken in 17 mL methanol in a 50 mL RB flask followed by the addition of arylaldehydes (7a-p; 0.001 mol). The reaction mixture was stirred for 2 h. After complete reaction, the distilled water was added and the resulting precipitates were filtered, washed with distilled water and dried to afford the title compounds.
Evaluation of antibacterial activity
The antibacterial activity assay was executed as reported in the literature [10, 11] . Antibacterial activity was performed in sterile 96-wells microplates under aseptic conditions. The variation in absorbance is noted which proportional to the microbial cell number is increasing in a log phase of growth.
Statistical analysis
All computations were executed in triplicate and statistical analysis was performed with Microsoft Excel 2010. The results are expressed as mean ± SEM (n = 3). Minimum inhibitory concentration (MIC) was computed with suitable dilutions (5 -30 µg/well) for each sample and results calculated using EZ-Fit software (Perrella Scientific Inc, Amherst, USA).
RESULTS
The target molecules, N'-substituted-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazide (8a-p) were synthesized as shown in Scheme-1. The synthesized compounds were further evaluated for the antibacterial activity. Nitrobenzylidene)-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio) N'-(3,4-Dimethoxybenzylidene)-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2 
N'-(2-

Antibacterial activity
The results of antibacterial activity results are shown in Tables 1 and 2 . The activities of synthesized molecules were found to be higher against various bacterial strains of gram negative bacteria as compared to such type of other molecules [12] [13] [14] [15] . The methylbenzylidenes (8b, 8c & 8d) and nitrobenzylidene (8h, 8i & 8j) showed the least activities except for p-substituted. Overall 8a, 8b, 8c, 8d, 8h, 8i and 8p executed a little low activity against some of bacterial strains. Among Gramnegative bacterial strains, 8p was the most active against S. typhi with MIC value of 10.04 ± 1.25 µM relative to the reference standard, ciprofloxacin with MIC value of 9.13 ± 2.00 µM and 8e against E. coli with MIC value of 9.45 ± 1.00 µM relative to 8.90 ± 1.65 µM. The potent activities of 8p and 8e may be due to 3,4-dimethoxy and 2-hydroxy benzylidenes respectively.
